News
Case Studies :


  • Mercury Therapeutics

    Taking AMPK target knowledge (no crystal structure), implementing four FTE medicinal chemistry programs and generating an orally bioavailable developmental candidate through scaffold morphing, lead generation and lead optimization iterations in nine months. Participated in due diligence by potential investors. IP was generated.

  • MaxThera

    Taking a 10 micromolar anti-infective lead compound to a sub-nanomolar advanced lead candidate in six months. IP was generated.

  • Augusta Therapeutics

    Designing 100-membered optimized libraries and delivering two micromlar lead compounds.

 
News
  CreaGen Inc. makes into the 2018 list of major players in CRO industry
https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO https://themobileherald.com/contract-research-organization-market-industry-growth-and-forecast-analysis-report-till-2024/24870/ https://www.businesswire.com/news/home/20180412005808/en/Outsourcing-Drug-Discovery-Contract-Research-Organization-CRO   more...
 
 
Home  |  About Us  |  Services  |  Products  |  R&D  |  News  |  Careers  |  Contact us Copyright © 2013 CreaGen Biosciences Inc. All rights reserved.